Genetics of ankylosing spondylitis

Molecular Immunology

Volumn 57, Issue 1, 2014, Pages 2-11

  Robinson, Philip C ^a   Brown, Matthew A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Ankylosing spondylitis; Single nucleotide polymorphism association; Spondyloarthritis

Indexed keywords

AMINOPEPTIDASE; G PROTEIN COUPLED RECEPTOR; HLA B27 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 23; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SPACER DNA;

ALLELE; ANKYLOSING SPONDYLITIS; ARTHRITIS; ENTERITIS; FIRST DEGREE RELATIVE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; IRIDOCYCLITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; ONSET AGE; PLEIOTROPY; PRIORITY JOURNAL; PSORIASIS; RECURRENCE RISK; REVIEW; RISK FACTOR; SECOND DEGREE RELATIVE; SPONDYLARTHRITIS; UBIQUITINATION;

ANKYLOSING SPONDYLITIS; SINGLE NUCLEOTIDE POLYMORPHISM ASSOCIATION; SPONDYLOARTHRITIS;

AMINOPEPTIDASES; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-23; MAJOR HISTOCOMPATIBILITY COMPLEX; PSORIASIS; SACROILIAC JOINT; SPINE; SPONDYLITIS, ANKYLOSING; UVEITIS, ANTERIOR;

EID: 84884411389     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.06.013     Document Type: Review

References (148)

1. Aaron S., Miller M.L., Howard J., Fraser P.A., Jackson J.M., Larson M.G., Glass D.N. Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis with peripheral arthritis. Journal of Rheumatology 1985, 12:553-557.
2. Adamopoulos I.E., Tessmer M., Chao C.C., Adda S., Gorman D., Petro M., Chou C.C., Pierce R.H., Yao W., Lane N.E., Laface D., Bowman E.P. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. Journal of Immunology 2011, 187:951-959.
3. Akkad N., Schatz M., Dengjel J., Tenzer S., Schild H. Census of cytosolic aminopeptidase activity reveals two novel cytosolic aminopeptidases. Medical Microbiology and Immunology 2012, 201:463-473.
4. Andres A.M., Dennis M.Y., Kretzschmar W.W., Cannons J.L., Lee-Lin S.Q., Hurle B., Schwartzberg P.L., Williamson S.H., Bustamante C.D., Nielsen R., Clark A.G., Green E.D. Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genetics 2010, 6:e1001157.
5. Armas J.B., Gonzalez S., Martinez-Borra J., Laranjeira F., Ribeiro E., Correia J., Ferreira M.L., Toste M., Lopez-Vazquez A., Lopez-Larrea C. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles. Tissue Antigens 1999, 53:237-243.
6. Armstrong R.D., Panayi G.S., Welsh K.I. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Annals of the Rheumatic Diseases 1983, 42:142-146.
7. Atan D., Fraser-Bell S., Plskova J., Kuffova L., Hogan A., Tufail A., Kilmartin D.J., Forrester J.V., Bidwell J., Dick A.D., Churchill A.J. Cytokine polymorphism in noninfectious uveitis. Investigative Ophthalmology and Visual Science 2010, 51:4133-4142.
8. Baerlecken N.T., Nothdorft S., Stummvoll G.H., Sieper J., Rudwaleit M., Reuter S., Matthias T., Schmidt R.E., Witte T. Autoantibodies against CD74 in spondyloarthritis. Annals of the Rheumatic Diseases 2013.
9. Baraliakos X., Baerlecken N., Witte T., Heldmann F., Braun J. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Annals of the Rheumatic Diseases 2013.
10. Bergboer J.G., Zeeuwen P.L., Schalkwijk J. Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. Journal of Investigative Dermatology 2012, 132:2320-2321.
11. Birtley J.R., Saridakis E., Stratikos E., Mavridis I.M. The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing. Biochemistry 2012, 51:286-295.
12. Blanchard N., Gonzalez F., Schaeffer M., Joncker N.T., Cheng T., Shastri A.J., Robey E.A., Shastri N. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nature Immunology 2008, 9:937-944.
13. Boldizsar F., Tarjanyi O., Nemeth P., Mikecz K., Glant T.T. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. International Immunology 2009, 21:511-522.
14. Brenner O., Levanon D., Negreanu V., Golubkov O., Fainaru O., Woolf E., Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:16016-16021.
15. Brewerton D.A., Caffrey M., Nicholls A., Walters D., James D.C. Acute anterior uveitis and HL-A 27. Lancet 1973, 302:994-996.
16. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet 1973, 1:904-907.
17. Brophy S., Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. Journal of Rheumatology 2001, 28:2283-2288.
18. Brown M.A. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 2008, 47:132-137.
19. Brown M.A. Genetics and the pathogenesis of ankylosing spondylitis. Current Opinion in Rheumatology 2009, 21:318-323.
20. Brown M.A., Pile K.D., Kennedy L.G., Calin A., Darke C., Bell J., Wordsworth B.P., Cornelis F. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Annals of the Rheumatic Diseases 1996, 55:268-270.
21. Brown M.A., Kennedy L.G., MacGregor A.J., Darke C., Duncan E., Shatford J.L., Taylor A., Calin A., Wordsworth P. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis and Rheumatism 1997, 40:1823-1828.
22. Brown M.A., Kennedy L.G., Darke C., Gibson K., Pile K.D., Shatford J.L., Taylor A., Calin A., Wordsworth B.P. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis and Rheumatism 1998, 41:460-465.
23. Brown M.A., Laval S.H., Brophy S., Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Annals of the Rheumatic Diseases 2000, 59:883-886.
24. Brown M.A., Brophy S., Bradbury L., Hamersma J., Timms A., Laval S., Cardon L., Calin A., Wordsworth B.P. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis and Rheumatism 2003, 48:2234-2239.
25. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., Todd J.A., Donnelly P., Barrett J.C., Davison D., Easton D., Evans D.M., Leung H.T., Marchini J.L., Morris A.P., Spencer C.C., Tobin M.D., Attwood A.P., Boorman J.P., Cant B., Everson U., Hussey J.M., Jolley J.D., Knight A.S., Koch K., Meech E., Nutland S., Prowse C.V., Stevens H.E., Taylor N.C., Walters G.R., Walker N.M., Watkins N.A., Winzer T., Jones R.W., McArdle W.L., Ring S.M., Strachan D.P., Pembrey M., Breen G., St Clair D., Caesar S., Gordon-Smith K., Jones L., Fraser C., Green E.K., Grozeva D., Hamshere M.L., Holmans P.A., Jones I.R., Kirov G., Moskivina V., Nikolov I., O'Donovan M.C., Owen M.J., Collier D.A., Elkin A., Farmer A., Williamson R., McGuffin P., Young A.H., Ferrier I.N., Ball S.G., Balmforth A.J., Barrett J.H., Bishop T.D., Iles M.M., Maqbool A., Yuldasheva N., Hall A.S., Braund P.S., Dixon R.J., Mangino M., Stevens S., Thompson J.R., Bredin F., Tremelling M., Parkes M., Drummond H., Lees C.W., Nimmo E.R., Satsangi J., Fisher S.A., Forbes A., Lewis C.M., Onnie C.M., Prescott N.J., Sanderson J., Matthew C.G., Barbour J., Mohiuddin M.K., Todhunter C.E., Mansfield J.C., Ahmad T., Cummings F.R., Jewell D.P., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 2007, 39:1329-1337.
26. Caffrey M.F., James D.C. Human lymphocyte antigen association in ankylosing spondylitis. Nature 1973, 242:121.
27. Calin A., Marder A., Becks E., Burns T. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis and Rheumatism 1983, 26:1460-1464.
28. Candeias S., Peschon J.J., Muegge K., Durum S.K. Defective T-cell receptor gamma gene rearrangement in interleukin-7 receptor knockout mice. Immunology Letters 1997, 57:9-14.
29. Chang S.C., Momburg F., Bhutani N., Goldberg A.L. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17107-17112.
30. Chapman J.A., Kirkness E.F., Simakov O., Hampson S.E., Mitros T., Weinmaier T., Rattei T., Balasubramanian P.G., Borman J., Busam D., Disbennett K., Pfannkoch C., Sumin N., Sutton G.G., Viswanathan L.D., Walenz B., Goodstein D.M., Hellsten U., Kawashima T., Prochnik S.E., Putnam N.H., Shu S., Blumberg B., Dana C.E., Gee L., Kibler D.F., Law L., Lindgens D., Martinez D.E., Peng J., Wigge P.A., Bertulat B., Guder C., Nakamura Y., Ozbek S., Watanabe H., Khalturin K., Hemmrich G., Franke A., Augustin R., Fraune S., Hayakawa E., Hayakawa S., Hirose M., Hwang J.S., Ikeo K., Nishimiya-Fujisawa C., Ogura A., Takahashi T., Steinmetz P.R., Zhang X., Aufschnaiter R., Eder M.K., Gorny A.K., Salvenmoser W., Heimberg A.M., Wheeler B.M., Peterson K.J., Bottger A., Tischler P., Wolf A., Gojobori T., Remington K.A., Strausberg R.L., Venter J.C., Technau U., Hobmayer B., Bosch T.C., Holstein T.W., Fujisawa T., Bode H.R., David C.N., Rokhsar D.S., Steele R.E. The dynamic genome of Hydra. Nature 2010, 464:592-596.
31. Choi C.B., Kim T.H., Jun J.B., Lee H.S., Shim S.C., Lee B., Pope A., Uddin M., Rahman P., Inman R.D. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Annals of the Rheumatic Diseases 2010, 69:582-584.
32. Ciccia F., Bombardieri M., Principato A., Giardina A., Tripodo C., Porcasi R., Peralta S., Franco V., Giardina E., Craxi A., Pitzalis C., Triolo G. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis and Rheumatism 2009, 60:955-965.
33. Ciccia F., Accardo-Palumbo A., Alessandro R., Rizzo A., Principe S., Peralta S., Raiata F., Giardina A., De Leo G., Triolo G. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis and Rheumatism 2012, 64:1869-1878.
34. Ciccia F., Accardo-Palumbo A., Rizzo A., Guggino G., Raimondo S., Giardina A., Cannizzaro A., Alessandro R., Triolo G. Autophagy, but not the HLA-B27 misfolding or the unfolded protein response, regulates the expression of IL-23 in the gut of patients with Ankylosing Spondylitis and subclinical gut inflammation. Annals of the Rheumatic Diseases 2013, (in press).
35. Costello M.-E., Elewaut D., Kenna T., Brown M.A. Microbes, the gut and ankylosing spondylitis. Arthritis Research & Therapy 2013, 15(3):214.
36. Cotsapas C., Voight B.F., Rossin E., Lage K., Neale B.M., Wallace C., Abecasis G.R., Barrett J.C., Behrens T., Cho J., De Jager P.L., Elder J.T., Graham R.R., Gregersen P., Klareskog L., Siminovitch K.A., van Heel D.A., Wijmenga C., Worthington J., Todd J.A., Hafler D.A., Rich S.S., Daly M.J., Consortia F.O.N.o. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genetics 2011, 7:e1002254.
37. Cruz-Guilloty F., Pipkin M.E., Djuretic I.M., Levanon D., Lotem J., Lichtenheld M.G., Groner Y., Rao A. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. Journal of Experimental Medicine 2009, 206:51-59.
38. Cui X., Hawari F., Alsaaty S., Lawrence M., Combs C.A., Geng W., Rouhani F.N., Miskinis D., Levine S.J. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Journal of Clinical Investigation 2002, 110:515-526.
39. Cui X., Rouhani F.N., Hawari F., Levine S.J. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. Journal of Biological Chemistry 2003, 278:28677-28685.
40. Cui X., Rouhani F.N., Hawari F., Levine S.J. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. Journal of Immunology 2003, 171:6814-6819.
41. Danoy P., Pryce K., Hadler J., Bradbury L.A., Farrar C., Pointon J., Ward M., Weisman M., Reveille J.D., Wordsworth B.P., Stone M.A., Maksymowych W.P., Rahman P., Gladman D., Inman R.D., Brown M.A. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genetics 2010, 6:e1001195.
42. Davidson S.I., Wu X., Liu Y., Wei M., Danoy P.A., Thomas G., Cai Q., Sun L., Duncan E., Wang N., Yu Q., Xu A., Fu Y., Brown M.A., Xu H. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis and Rheumatism 2009, 60:3263-3268.
43. Davidson S.I., Liu Y., Danoy P.A., Wu X., Thomas G.P., Jiang L., Sun L., Wang N., Han J., Han H., Visscher P.M., Brown M.A., Xu H. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Annals of the Rheumatic Diseases 2011, 70:289-292.
44. Davidson S.I., Jiang L., Cortes A., Wu X., Glazov E.A., Donskoi M., Zheng Y., Danoy P.A., Liu Y., Thomas G.P., Brown M.A., Xu H. High throughput sequencing of IL23R reveals a low-frequency non-synonymous SNP that is associated with Ankylosing spondylitis in a Han Chinese population. Arthritis and Rheumatism 2013, 65(7):1747-1752.
45. Dehghan A., Dupuis J., Barbalic M., Bis J.C., Eiriksdottir G., Lu C., Pellikka N., Wallaschofski H., Kettunen J., Henneman P., Baumert J., Strachan D.P., Fuchsberger C., Vitart V., Wilson J.F., Pare G., Naitza S., Rudock M.E., Surakka I., de Geus E.J., Alizadeh B.Z., Guralnik J., Shuldiner A., Tanaka T., Zee R.Y., Schnabel R.B., Nambi V., Kavousi M., Ripatti S., Nauck M., Smith N.L., Smith A.V., Sundvall J., Scheet P., Liu Y., Ruokonen A., Rose L.M., Larson M.G., Hoogeveen R.C., Freimer N.B., Teumer A., Tracy R.P., Launer L.J., Buring J.E., Yamamoto J.F., Folsom A.R., Sijbrands E.J., Pankow J., Elliott P., Keaney J.F., Sun W., Sarin A.P., Fontes J.D., Badola S., Astor B.C., Hofman A., Pouta A., Werdan K., Greiser K.H., Kuss O., Meyer zu Schwabedissen H.E., Thiery J., Jamshidi Y., Nolte I.M., Soranzo N., Spector T.D., Volzke H., Parker A.N., Aspelund T., Bates D., Young L., Tsui K., Siscovick D.S., Guo X., Rotter J.I., Uda M., Schlessinger D., Rudan I., Hicks A.A., Penninx B.W., Thorand B., Gieger C., Coresh J., Willemsen G., Harris T.B., Uitterlinden A.G., Jarvelin M.R., Rice K., Radke D., Salomaa V., Willems van Dijk K., Boerwinkle E., Vasan R.S., Ferrucci L., Gibson Q.D., Bandinelli S., Snieder H., Boomsma D.I., Xiao X., Campbell H., et al. Meta-analysis of genome-wide association studies in >80000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011, 123:731-738.
46. DeLay M.L., Turner M.J., Klenk E.I., Smith J.A., Sowders D.P., Colbert R.A. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis and Rheumatism 2009, 60:2633-2643.
47. Dendrou C.A., Fung E., Esposito L., Todd J.A., Wicker L.S., Plagnol V. Fluorescence intensity normalisation: correcting for time effects in large-scale flow cytometric analysis. Advances in Bioinformatics 2009, 476106.
48. Desterro J.M., Thomson J., Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Letters 1997, 417:297-300.
49. Di Meglio P., Di Cesare A., Laggner U., Chu C.C., Napolitano L., Villanova F., Tosi I., Capon F., Trembath R.C., Peris K., Nestle F.O. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE 2011, 6:e17160.
50. Djouadi K., Nedelec B., Tamouza R., Genin E., Ramasawmy R., Charron D., Delpech M., Laoussadi S. Interleukin 1 gene cluster polymorphisms in multiplex families with spondylarthropathies. Cytokine 2001, 13:98-103.
51. Dutoit R., Brandt N., Legrain C., Bauvois C. Functional characterization of two M42 aminopeptidases erroneously annotated as cellulases. PLoS ONE 2012, 7:e50639.
52. European Bioinformatics Database Immuno Polymorphism Database International ImMunoGeneTics project/Human Leucocyte Antigen Database - Release 3.12.0, 2013-04-17 2013, (26.05.13).
53. Evans D.M., Spencer C.C., Pointon J.J., Su Z., Harvey D., Kochan G., Opperman U., Dilthey A., Pirinen M., Stone M.A., Appleton L., Moutsianis L., Leslie S., Wordsworth T., Kenna T.J., Karaderi T., Thomas G.P., Ward M.M., Weisman M.H., Farrar C., Bradbury L.A., Danoy P., Inman R.D., Maksymowych W., Gladman D., Rahman P., Morgan A., Marzo-Ortega H., Bowness P., Gaffney K., Gaston J.S., Smith M., Bruges-Armas J., Couto A.R., Sorrentino R., Paladini F., Ferreira M.A., Xu H., Liu Y., Jiang L., Lopez-Larrea C., Diaz-Pena R., Lopez-Vazquez A., Zayats T., Band G., Bellenguez C., Blackburn H., Blackwell J.M., Bramon E., Bumpstead S.J., Casas J.P., Corvin A., Craddock N., Deloukas P., Dronov S., Duncanson A., Edkins S., Freeman C., Gillman M., Gray E., Gwilliam R., Hammond N., Hunt S.E., Jankowski J., Jayakumar A., Langford C., Liddle J., Markus H.S., Mathew C.G., McCann O.T., McCarthy M.I., Palmer C.N., Peltonen L., Plomin R., Potter S.C., Rautanen A., Ravindrarajah R., Ricketts M., Samani N., Sawcer S.J., Strange A., Trembath R.C., Viswanathan A.C., Waller M., Weston P., Whittaker P., Widaa S., Wood N.W., McVean G., Reveille J.D., Wordsworth B.P., Brown M.A., Donnelly P. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics 2011, 43:761-767.
54. Evnouchidou I., Momburg F., Papakyriakou A., Chroni A., Leondiadis L., Chang S.C., Goldberg A.L., Stratikos E. The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS ONE 2008, 3:e3658.
55. Evnouchidou I., Birtley J., Seregin S., Papakyriakou A., Zervoudi E., Samiotaki M., Panayotou G., Giastas P., Petrakis O., Georgiadis D., Amalfitano A., Saridakis E., Mavridis I.M., Stratikos E. A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing. Journal of Immunology 2012, 189:2383-2392.
56. Feldtkeller E., Khan M.A., van der Heijde D., van der Linden S., Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatology International 2003, 23:61-66.
57. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., Lees C.W., Balschun T., Lee J., Roberts R., Anderson C.A., Bis J.C., Bumpstead S., Ellinghaus D., Festen E.M., Georges M., Green T., Haritunians T., Jostins L., Latiano A., Mathew C.G., Montgomery G.W., Prescott N.J., Raychaudhuri S., Rotter J.I., Schumm P., Sharma Y., Simms L.A., Taylor K.D., Whiteman D., Wijmenga C., Baldassano R.N., Barclay M., Bayless T.M., Brand S., Buning C., Cohen A., Colombel J.F., Cottone M., Stronati L., Denson T., De Vos M., D'Inca R., Dubinsky M., Edwards C., Florin T., Franchimont D., Gearry R., Glas J., Van Gossum A., Guthery S.L., Halfvarson J., Verspaget H.W., Hugot J.P., Karban A., Laukens D., Lawrance I., Lemann M., Levine A., Libioulle C., Louis E., Mowat C., Newman W., Panes J., Phillips A., Proctor D.D., Regueiro M., Russell R., Rutgeerts P., Sanderson J., Sans M., Seibold F., Steinhart A.H., Stokkers P.C., Torkvist L., Kullak-Ublick G., Wilson D., Walters T., Targan S.R., Brant S.R., Rioux J.D., D'Amato M., Weersma R.K., Kugathasan S., Griffiths A.M., Mansfield J.C., Vermeire S., Duerr R.H., Silverberg M.S., Satsangi J., Schreiber S., Cho J.H., Annese V., Hakonarson H., Daly M.J., Parkes M. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genetics 2010, 42:1118-1125.
58. Garcia F., Rognan D., Lamas J.R., Marina A., Lopez de Castro J.A. An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 1998, 51:1-9.
59. Garcia-Fernandez S., Gonzalez S., Mina Blanco A., Martinez-Borra J., Blanco-Gelaz M., Lopez-Vazquez A., Lopez-Larrea C. New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001, 58:259-262.
60. Garcia-Medel N., Sanz-Bravo A., Van Nguyen D., Galocha B., Gomez-Molina P., Martin-Esteban A., Alvarez-Navarro C., de Castro J.A. Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Molecular and Cellular Proteomics 2012, 11:1416-1429.
61. Gonzalez-Roces S., Alvarez M.V., Gonzalez S., Dieye A., Makni H., Woodfield D.G., Housan L., Konenkov V., Abbadi M.C., Grunnet N., Coto E., Lopez-Larrea C. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997, 49:116-123.
62. Goto Y., Ogawa K., Hattori A., Tsujimoto M. Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-gamma. Journal of Biological Chemistry 2011, 286:21906-21914.
63. Gregory A.P., Dendrou C.A., Attfield K.E., Haghikia A., Xifara D.K., Butter F., Poschmann G., Kaur G., Lambert L., Leach O.A., Promel S., Punwani D., Felce J.H., Davis S.J., Gold R., Nielsen F.C., Siegel R.M., Mann M., Bell J.I., McVean G., Fugger L. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
64. Haibel H., Rudwaleit M., Listing J., Sieper J. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Annals of the Rheumatic Diseases 2005, 64:296-298.
65. Hammer G.E., Gonzalez F., Champsaur M., Cado D., Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nature Immunology 2006, 7:103-112.
66. Haroon N., Tsui F.W., Chiu B., Tsui H.W., Inman R.D. Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. Journal of Rheumatology 2010, 37:1907-1910.
67. Harvey D., Pointon J.J., Karaderi T., Appleton L.H., Farrar C., Wordsworth B.P. A common functional variant of endoplasmic reticulum aminopeptidase 2 (ERAP2) that reduces major histocompatibility complex class I expression is not associated with ankylosing spondylitis. Rheumatology 2011, 50:1720-1721.
68. Hearn A., York I.A., Bishop C., Rock K.L. Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation. Journal of Immunology 2010, 184:4725-4732.
69. Heltzer M.L., Coffin S.E., Maurer K., Bagashev A., Zhang Z., Orange J.S., Sullivan K.E. Immune dysregulation in severe influenza. Journal of Leukocyte Biology 2009, 85:1036-1043.
70. Hinks A., Cobb J., Marion M.C., Prahalad S., Sudman M., Bowes J., Martin P., Comeau M.E., Sajuthi S., Andrews R., Brown M., Chen W.M., Concannon P., Deloukas P., Edkins S., Eyre S., Gaffney P.M., Guthery S.L., Guthridge J.M., Hunt S.E., James J.A., Keddache M., Moser K.L., Nigrovic P.A., Onengut-Gumuscu S., Onslow M.L., Rose C.D., Rich S.S., Steel K.J., Wakeland E.K., Wallace C.A., Wedderburn L.R., Woo P., Boston Children's J.I.A.R., British Society of P., Adolescent Rheumatology Study G., Childhood Arthritis Prospective S., Childhood Arthritis Response to Medication S., German Society for Pediatric R., Study J.I.A.G.E., Registry N.J.G., Study T., United Kingdom Juvenile Idiopathic Arthritis Genetics C., Bohnsack J.F., Haas J.P., Glass D.N., Langefeld C.D., Thomson W., Thompson S.D. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nature Genetics 2013, 45(6):664-669.
71. International Genetics of Ankylosing Spondylitis C., Cortes A., Hadler J., Pointon J.P., Robinson P.C., Karaderi T., Leo P., Cremin K., Pryce K., Harris J., Lee S., Joo K.B., Shim S.C., Weisman M., Ward M., Zhou X., Garchon H.J., Chiocchia G., Nossent J., Lie B.A., Forre O., Tuomilehto J., Laiho K., Jiang L., Liu Y., Wu X., Bradbury L.A., Elewaut D., Burgos-Vargas R., Stebbings S., Appleton L., Farrah C., Lau J., Kenna T.J., Haroon N., Ferreira M.A., Yang J., Mulero J., Fernandez-Sueiro J.L., Gonzalez-Gay M.A., Lopez-Larrea C., Deloukas P., Donnelly P., Australo-Anglo-American Spondyloarthritis C., Groupe Francaise d'Etude Genetique des S., Nord-Trondelag Health S., Spondyloarthritis Research Consortium of C., Wellcome Trust Case Control C., Bowness P., Gafney K., Gaston H., Gladman D.D., Rahman P., Maksymowych W.P., Xu H., Crusius J.B., van der Horst-Bruinsma I.E., Chou C.T., Valle-Onate R., Romero-Sanchez C., Hansen I.M., Pimentel-Santos F.M., Inman R.D., Videm V., Martin J., Breban M., Reveille J.D., Evans D.M., Kim T.H., Wordsworth B.P., Brown M.A. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature Genetics 2013, 45(7):730-738.
72. Intlekofer A.M., Banerjee A., Takemoto N., Gordon S.M., Dejong C.S., Shin H., Hunter C.A., Wherry E.J., Lindsten T., Reiner S.L. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008, 321:408-411.
73. Jaakkola E., Herzberg I., Laiho K., Barnardo M.C., Pointon J.J., Kauppi M., Kaarela K., Tuomilehto-Wolf E., Tuomilehto J., Wordsworth B.P., Brown M.A. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Annals of the Rheumatic Diseases 2006, 65:775-780.
74. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nature Reviews Immunology 2012, 12:557-569.
75. Kadi A., Izac B., Said-Nahal R., Leboime A., Van Praet L., de Vlam K., Elewaut D., Chiocchia G., Breban M. Investigating the genetic association between ERAP1 and spondyloarthritis. Annals of the Rheumatic Diseases 2013, 72:608-613.
76. Kenna T.J., Brown M.A. The role of IL-17-secreting mast cells in inflammatory joint disease. Nature reviews. Rheumatology 2013, 9(6):375-379.
77. Khan M., Kushner I., Braun W., Zachary A., Steinberg A. HLA-B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens 1978, 11:434-438.
78. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
79. Klose C.S., Kiss E.A., Schwierzeck V., Ebert K., Hoyler T., d'Hargues Y., Goppert N., Croxford A.L., Waisman A., Tanriver Y., Diefenbach A. A T-bet gradient controls the fate and function of CCR6(-)RORgammat(+) innate lymphoid cells. Nature 2013, 494(7436).
80. Kochan G., Krojer T., Harvey D., Fischer R., Chen L., Vollmar M., von Delft F., Kavanagh K.L., Brown M.A., Bowness P., Wordsworth P., Kessler B.M., Oppermann U. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:7745-7750.
81. Kontoyiannis D., Boulougouris G., Manoloukos M., Armaka M., Apostolaki M., Pizarro T., Kotlyarov A., Forster I., Flavell R., Gaestel M., Tsichlis P., Cominelli F., Kollias G. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. Journal of Experimental Medicine 2002, 196:1563-1574.
82. Kudo L.C., Parfenova L., Ren G., Vi N., Hui M., Ma Z., Lau K., Gray M., Bardag-Gorce F., Wiedau-Pazos M., Hui K.S., Karsten S.L. Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAU(P301L) double-transgenic mice. Human Molecular Genetics 2011, 20:1820-1833.
83. Levinson R.D. Killer immunoglobulin-like receptor genes in uveitis. Ocular Immunology and Inflammation 2011, 19:192-201.
84. Levinson R.D., Martin T.M., Luo L., Ashouri E., Rosenbaum J.T., Smith J.R., Austin C.R., Lutt J.R., Rajalingam R. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy. Investigative Ophthalmology and Visual Science 2010, 51:1505-1510.
85. Li C., Lin Z., Xie Y., Guo Z., Huang J., Wei Q., Li Q.X., Wang X., Cao S., Liao Z., Xu M., Shen Y., Gu J. ERAP1 Is associated with ankylosing spondylitis in Han Chinese. Journal of Rheumatology 2010, 38:317-321.
86. Lin Z., Bei J.X., Shen M., Li Q., Liao Z., Zhang Y., Lv Q., Wei Q., Low H.Q., Guo Y.M., Cao S., Yang M., Hu Z., Xu M., Wang X., Wei Y., Li L., Li C., Li T., Huang J., Pan Y., Jin O., Wu Y., Wu J., Guo Z., He P., Hu S., Wu H., Song H., Zhan F., Liu S., Gao G., Liu Z., Li Y., Xiao C., Li J., Ye Z., He W., Liu D., Shen L., Huang A., Tao Y., Pan X., Yu B., Tai E.S., Zeng Y.X., Ren E.C., Shen Y., Liu J., Gu J. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nature Genetics 2011, 44:73-77.
87. Lin R., Charlesworth J., Stankovich J., Perreau V.M., Brown M.A., gene C., Taylor B.V. Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. PLoS ONE 2013, 8:e56379.
88. Lopez-Larrea C., Sujirachato K., Mehra N.K., Chiewsilp P., Isarangkura D., Kanga U., Dominguez O., Coto E., Pena M., Setien F., et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis, evidence for new associations. Tissue Antigens 1995, 45:169-176.
89. MacLean I.L., Iqball S., Woo P., Keat A.C., Hughes R.A., Kingsley G.H., Knight S.C. HLA-B27 subtypes in the spondarthropathies. Clinical and Experimental Immunology 1993, 91:214-219.
90. Maksymowych W.P., Inman R.D., Gladman D.D., Reeve J.P., Pope A., Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis and Rheumatism 2009, 60:1317-1323.
91. Marazziti D., Di Pietro C., Golini E., Mandillo S., Matteoni R., Tocchini-Valentini G.P. Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor. FASEB Journal 2009, 23:1978-1987.
92. Martin T.M., Rosenbaum J.T. An update on the genetics of HLA B27-associated acute anterior uveitis. Ocular Immunology and Inflammation 2011, 19:108-114.
93. Martin T.M., Zhang G., Luo J., Jin L., Doyle T.M., Rajska B.M., Coffman J.E., Smith J.R., Becker M.D., Mackensen F., Khan M.A., Levinson R.D., Schumacher H.R., Wade N.K., Rosenbaum J.T., Reveille J.D. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis and Rheumatism 2005, 52:269-274.
94. McLean I.L., Adams D.D., Highton J. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model. Journal of Clinical and Laboratory Immunology 1985, 18:123-127.
95. Mehta A.M., Jordanova E.S., van Wezel T., Uh H.W., Corver W.E., Kwappenberg K.M., Verduijn W., Kenter G.G., van der Burg S.H., Fleuren G.J. Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes, Chromosomes & Cancer 2007, 46:577-586.
96. Menzies F.M., Hourez R., Imarisio S., Raspe M., Sadiq O., Chandraratna D., O'Kane C., Rock K.L., Reits E., Goldberg A.L., Rubinsztein D.C. Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Human Molecular Genetics 2010, 19:4573-4586.
97. Miehle W., Schattenkirchner M., Albert D., Bunge M. HLA-DR4 in ankylosing spondylitis with different patterns of joint involvement. Annals of the Rheumatic Diseases 1985, 44:39-44.
98. Muller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nature Reviews Molecular Cell Biology 2001, 2:202-210.
99. Muto A., Tashiro S., Nakajima O., Hoshino H., Takahashi S., Sakoda E., Ikebe D., Yamamoto M., Igarashi K. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 2004, 429:566-571.
100. Nguyen T.T., Chang S.C., Evnouchidou I., York I.A., Zikos C., Rock K.L., Goldberg A.L., Stratikos E., Stern L.J. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nature Structural & Molecular Biology 2011, 18:604-613.
101. Pallotta M.T., Orabona C., Volpi C., Vacca C., Belladonna M.L., Bianchi R., Servillo G., Brunacci C., Calvitti M., Bicciato S., Mazza E.M., Boon L., Grassi F., Fioretti M.C., Fallarino F., Puccetti P., Grohmann U. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nature Immunology 2011, 12:870-878.
102. Park J.H., Adoro S., Guinter T., Erman B., Alag A.S., Catalfamo M., Kimura M.Y., Cui Y., Lucas P.J., Gress R.E., Kubo M., Hennighausen L., Feigenbaum L., Singer A. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nature Immunology 2010, 11:257-264.
103. Pearce E.L., Mullen A.C., Martins G.A., Krawczyk C.M., Hutchins A.S., Zediak V.P., Banica M., DiCioccio C.B., Gross D.A., Mao C.A., Shen H., Cereb N., Yang S.Y., Lindsten T., Rossant J., Hunter C.A., Reiner S.L. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003, 302:1041-1043.
104. Pedersen O.B., Svendsen A.J., Ejstrup L., Skytthe A., Harris J.R., Junker P. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scandinavian Journal of Rheumatology 2008, 37:120-126.
105. Pickart C.M. Mechanisms underlying ubiquitination. Annual Review of Biochemistry 2001, 70:503-533.
106. Pimentel-Santos F.M., Ligeiro D., Matos M., Mourao A.F., Sousa E., Pinto P., Ribeiro A., Sousa M., Barcelos A., Godinho F., Cruz M., Fonseca J.E., Guedes-Pinto H., Trindade H., Evans D.M., Brown M.A., Branco J.C. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clinical and Experimental Rheumatology 2009, 27:800-806.
107. Polley H.F., Slocumb C.H. Rheumatoid spondylitis: a study of 1,035 cases. Annals of Internal Medicine 1947, 26:240-249.
108. Queiro R., Alperi M., Lopez A., Sarasqueta C., Riestra J.L., Ballina J. Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis. Joint, Bone, Spine 2008, 75:544-547.
109. Rakowski L.A., Garagiola D.D., Li C.M., Decker M., Caruso S., Jones M., Kuick R., Cierpicki T., Maillard I., Chiang M.Y. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. Cancer Research 2013, 73(2):930-941.
110. Ren G., Su J., Zhang L., Zhao X., Ling W., L'Huillie A., Zhang J., Lu Y., Roberts A.I., Ji W., Zhang H., Rabson A.B., Shi Y. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009, 27:1954-1962.
111. Reveille J.D., Inman R., Khan M., Yu D.T.K., Jin L. Family studies in ankylosing spondylitis: microsatellite analysis of 55 concordant sib pairs. Journal of Rheumatology 2000, 27:5.
112. Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., Pointon J.J., Jin R., Zhou X., Bradbury L.A., Appleton L.H., Davis J.C., Diekman L., Doan T., Dowling A., Duan R., Duncan E.L., Farrar C., Hadler J., Harvey D., Karaderi T., Mogg R., Pomeroy E., Pryce K., Taylor J., Savage L., Deloukas P., Kumanduri V., Peltonen L., Ring S.M., Whittaker P., Glazov E., Thomas G.P., Maksymowych W.P., Inman R.D., Ward M.M., Stone M.A., Weisman M.H., Wordsworth B.P., Brown M.A. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature Genetics 2010, 42:123-127.
113. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., Green T., Kuballa P., Barmada M.M., Datta L.W., Shugart Y.Y., Griffiths A.M., Targan S.R., Ippoliti A.F., Bernard E.J., Mei L., Nicolae D.L., Regueiro M., Schumm L.P., Steinhart A.H., Rotter J.I., Duerr R.H., Cho J.H., Daly M.J., Brant S.R. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature Genetics 2007, 39:596-604.
114. Robinson P.C., Brown M.A. The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheumatic Diseases Clinics of North America 2012, 38:539-553.
115. Robinson W.P., van der Linden S.M., Khan M.A., Rentsch H.U., Cats A., Russell A., Thomson G. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis and Rheumatism 1989, 32:1135-1141.
116. Robinson P.C., Wordsworth B.P., Reveille J.D., Brown M.A. Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis. Annals of the Rheumatic Diseases 2013, 72:162-164.
117. Rosenbaum D.M., Rasmussen S.G., Kobilka B.K. The structure and function of G-protein-coupled receptors. Nature 2009, 459:356-363.
118. Rudwaleit M., van der Heijde D., Landewe R., Listing J., Akkoc N., Brandt J., Braun J., Chou C.T., Collantes-Estevez E., Dougados M., Huang F., Gu J., Khan M.A., Kirazli Y., Maksymowych W.P., Mielants H., Sorensen I.J., Ozgocmen S., Roussou E., Valle-Onate R., Weber U., Wei J., Sieper J. The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (Part II): validation and final selection. Annals of the Rheumatic Diseases 2009, 68:777-783.
119. Ruutu M., Thomas G., Steck R., Degli Esposti M.A., Zinkernagel M.S., Alexander K., Velasco J., Strutton G., Tran A., Benham H., Rehaume L., Wilson R.J., Kikly k., Davies J., Pettit A.R., Brown M.A., Thomas R. Fungal beta-glucan triggers spondyloarthropathy and Crohn's disease in SKG mice. Arthritis & Rheumatism 2012, 64(7):2211-2222.
120. Sanmarti R., Ercilla M.G., Brancos M.A., Cid M.C., Collado A., Rotes-Querol J. HLA class II antigens (DR, DQ loci) and peripheral arthritis in ankylosing spondylitis. Annals of the Rheumatic Diseases 1987, 46:497-500.
121. Sarin R., Wu X., Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:9560-9565.
122. Saveanu L., Fruci D., van Endert P. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases. Molecular Immunology 2002, 39:203-215.
123. Saveanu L., Carroll O., Lindo V., Del Val M., Lopez D., Lepelletier Y., Greer F., Schomburg L., Fruci D., Niedermann G., van Endert P.M. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nature Immunology 2005, 6:689-697.
124. Saveanu L., Carroll O., Weimershaus M., Guermonprez P., Firat E., Lindo V., Greer F., Davoust J., Kratzer R., Keller S.R., Niedermann G., van Endert P. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 2009, 325:213-217.
125. Schlosstein L., Terasaki P.I., Bluestone R., Pearson C.M. High association of an HL-A antigen, W27, with ankylosing spondylitis. New England Journal of Medicine 1973, 288:704-706.
126. Sciume G., Hirahara K., Takahashi H., Laurence A., Villarino A.V., Singleton K.L., Spencer S.P., Wilhelm C., Poholek A.C., Vahedi G., Kanno Y., Belkaid Y., O'Shea J.J. Distinct requirements for T-bet in gut innate lymphoid cells. Journal of Experimental Medicine 2012, 209:2331-2338.
127. Sherlock J.P., Joyce-Shaikh B., Turner S.P., Chao C.C., Sathe M., Grein J., Gorman D.M., Bowman E.P., McClanahan T.K., Yearley J.H., Eberl G., Buckley C.D., Kastelein R.A., Pierce R.H., Laface D.M., Cua D.J. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+ CD4-CD8- entheseal resident T cells. Nature Medicine 2012, 18:1069-1076.
128. Sims A.M., Barnardo M., Herzberg I., Bradbury L., Calin A., Wordsworth B.P., Darke C., Brown M.A. Non-B27 MHC associations of ankylosing spondylitis. Genes and Immunity 2007, 8:115-123.
129. Sims A.M., Timms A.E., Bruges-Armas J., Burgos-Vargas R., Chou C.T., Doan T., Dowling A., Fialho R.N., Gergely P., Gladman D.D., Inman R., Kauppi M., Kaarela K., Laiho K., Maksymowych W., Pointon J.J., Rahman P., Reveille J.D., Sorrentino R., Tuomilehto J., Vargas-Alarcon G., Wordsworth B.P., Xu H., Brown M.A. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Annals of the Rheumatic Diseases 2008, 67:1305-1309.
130. Song I.H., Heldmann F., Rudwaleit M., Listing J., Appel H., Haug-Rost I., Braun J., Sieper J. One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare. Annals of the Rheumatic Diseases 2013, 72:305-306.
131. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., Blackwell J.M., Bramon E., Bumpstead S.J., Casas J.P., Cork M.J., Corvin A., Deloukas P., Dilthey A., Duncanson A., Edkins S., Estivill X., Fitzgerald O., Freeman C., Giardina E., Gray E., Hofer A., Huffmeier U., Hunt S.E., Irvine A.D., Jankowski J., Kirby B., Langford C., Lascorz J., Leman J., Leslie S., Mallbris L., Markus H.S., Mathew C.G., McLean W.H., McManus R., Mossner R., Moutsianas L., Naluai A.T., Nestle F.O., Novelli G., Onoufriadis A., Palmer C.N., Perricone C., Pirinen M., Plomin R., Potter S.C., Pujol R.M., Rautanen A., Riveira-Munoz E., Ryan A.W., Salmhofer W., Samuelsson L., Sawcer S.J., Schalkwijk J., Smith C.H., Stahle M., Su Z., Tazi-Ahnini R., Traupe H., Viswanathan A.C., Warren R.B., Weger W., Wolk K., Wood N., Worthington J., Young H.S., Zeeuwen P.L., Hayday A., Burden A.D., Griffiths C.E., Kere J., Reis A., McVean G., Evans D.M., Brown M.A., Barker J.N., Peltonen L., Donnelly P., Trembath R.C. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature Genetics 2010, 42:985-990.
132. Tan A.L., Marzo-Ortega H., O'Connor P., Fraser A., Emery P., McGonagle D. Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Annals of the Rheumatic Diseases 2004, 63:1041-1045.
133. Tosa N., Murakami M., Jia W.Y., Yokoyama M., Masunaga T., Iwabuchi C., Inobe M., Iwabuchi K., Miyazaki T., Onoe K., Iwata M., Uede T. Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. International Immunology 2003, 15:741-749.
134. Tsoi L.C., Spain S.L., Knight J., Ellinghaus E., Stuart P.E., Capon F., Ding J., Li Y., Tejasvi T., Gudjonsson J.E., Kang H.M., Allen M.H., McManus R., Novelli G., Samuelsson L., Schalkwijk J., Stahle M., Burden A.D., Smith C.H., Cork M.J., Estivill X., Bowcock A.M., Krueger G.G., Weger W., Worthington J., Tazi-Ahnini R., Nestle F.O., Hayday A., Hoffmann P., Winkelmann J., Wijmenga C., Langford C., Edkins S., Andrews R., Blackburn H., Strange A., Band G., Pearson R.D., Vukcevic D., Spencer C.C., Deloukas P., Mrowietz U., Schreiber S., Weidinger S., Koks S., Kingo K., Esko T., Metspalu A., Lim H.W., Voorhees J.J., Weichenthal M., Wichmann H.E., Chandran V., Rosen C.F., Rahman P., Gladman D.D., Griffiths C.E., Reis A., Kere J., Collaborative Association Study of P., Genetic Analysis of Psoriasis C., Psoriasis Association Genetics E., Wellcome Trust Case Control C., Nair R.P., Franke A., Barker J.N., Abecasis G.R., Elder J.T., Trembath R.C. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics 2012, 44:1341-1348.
135. Tsui F.W., Haroon N., Reveille J.D., Rahman P., Chiu B., Tsui H.W., Inman R.D. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Annals of the Rheumatic Diseases 2010, 69:733-736.
136. van der Linden S., Valkenburg H., Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. British Journal of Rheumatology 1983, 22:18-19.
137. van der Paardt M., Crusius J.B., Garcia-Gonzalez M.A., Baudoin P., Kostense P.J., Alizadeh B.Z., Dijkmans B.A., Pena A.S., van der Horst-Bruinsma I.E. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 2002, 41:1419-1423.
138. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. American Journal of Human Genetics 2012, 90:7-24.
139. Wang J., Simonavicius N., Wu X., Swaminath G., Reagan J., Tian H., Ling L. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. Journal of Biological Chemistry 2006, 281:22021-22028.
140. Wang S., Adrianto I., Wiley G.B., Lessard C.J., Kelly J.A., Adler A.J., Glenn S.B., Williams A.H., Ziegler J.T., Comeau M.E., Marion M.C., Wakeland B.E., Liang C., Kaufman K.M., Guthridge J.M., Alarcon-Riquelme M.E., Biolupus, Networks G., Alarcon G.S., Anaya J.M., Bae S.C., Kim J.H., Joo Y.B., Boackle S.A., Brown E.E., Petri M.A., Ramsey-Goldman R., Reveille J.D., Vila L.M., Criswell L.A., Edberg J.C., Freedman B.I., Gilkeson G.S., Jacob C.O., James J.A., Kamen D.L., Kimberly R.P., Martin J., Merrill J.T., Niewold T.B., Pons-Estel B.A., Scofield R.H., Stevens A.M., Tsao B.P., Vyse T.J., Langefeld C.D., Harley J.B., Wakeland E.K., Moser K.L., Montgomery C.G., Gaffney P.M. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes and Immunity 2012, 13:380-387.
141. Wei J.C., Tsai W.C., Lin H.S., Tsai C.Y., Chou C.T. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology 2004, 43:839-842.
142. Weimershaus M., Evnouchidou I., Saveanu L., van Endert P. Peptidases trimming MHC class I ligands. Current Opinion in Immunology 2013, 25:90-96.
143. Wilk J.B., Walter R.E., Laramie J.M., Gottlieb D.J., O'Connor G.T. Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Medical Genetics 2007, 8(Suppl. 1):S8.
144. Yagi R., Junttila I.S., Wei G., Urban J.F., Zhao K., Paul W.E., Zhu J. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity 2010, 32:507-517.
145. Yang M.M., Lai T.Y., Tam P.O., Chiang S.W., Chan C.K., Luk F.O., Ng T.K., Pang C.P. CFH 184G as a genetic risk marker for anterior uveitis in Chinese females. Molecular Vision 2011, 17:2655-2664.
146. Yang M.M., Lai T.Y., Tam P.O., Chiang S.W., Ng T.K., Liu K., Pang C.P. Association of C2 and CFB polymorphisms with anterior uveitis. Investigative Ophthalmology and Visual Science 2012, 53:4969-4974.
147. York I.A., Chang S.C., Saric T., Keys J.A., Favreau J.M., Goldberg A.L., Rock K.L. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nature Immunology 2002, 3:1177-1184.
148. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nature Reviews Genetics 2009, 10:43-55.